Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD

74.86  -0.79 (-1.04%)

After market: 74.86 0 (0%)

Fundamental Rating

7

Overall ACLS gets a fundamental rating of 7 out of 10. We evaluated ACLS against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS gets an excellent profitability rating and is at the same time showing great financial health properties. ACLS may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make ACLS suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
In the past year ACLS had a positive cash flow from operations.
Each year in the past 5 years ACLS has been profitable.
Each year in the past 5 years ACLS had a positive operating cash flow.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.35%, ACLS belongs to the top of the industry, outperforming 83.64% of the companies in the same industry.
ACLS has a Return On Equity of 17.43%. This is amongst the best in the industry. ACLS outperforms 80.91% of its industry peers.
With an excellent Return On Invested Capital value of 14.18%, ACLS belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACLS is significantly above the industry average of 10.58%.
The 3 year average ROIC (21.38%) for ACLS is well above the current ROIC(14.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROIC 14.18%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS has a better Profit Margin (18.68%) than 79.09% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
ACLS has a better Operating Margin (19.21%) than 76.36% of its industry peers.
In the last couple of years the Operating Margin of ACLS has grown nicely.
The Gross Margin of ACLS (44.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

ACLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ACLS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACLS has less shares outstanding
Compared to 1 year ago, ACLS has an improved debt to assets ratio.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ACLS has an Altman-Z score of 7.10. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
ACLS has a better Altman-Z score (7.10) than 69.09% of its industry peers.
The Debt to FCF ratio of ACLS is 0.35, which is an excellent value as it means it would take ACLS, only 0.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 80.91% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ACLS (0.04) is better than 60.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 7.1
ROIC/WACC1.21
WACC11.68%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.57 indicates that ACLS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.57, ACLS belongs to the best of the industry, outperforming 82.73% of the companies in the same industry.
A Quick Ratio of 4.09 indicates that ACLS has no problem at all paying its short term obligations.
ACLS has a better Quick ratio (4.09) than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 5.57
Quick Ratio 4.09
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -25.76% in the last year.
ACLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.54% yearly.
The Revenue for ACLS has decreased by -15.14% in the past year. This is quite bad
ACLS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.30% yearly.
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%

3.2 Future

ACLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.02% yearly.
The Revenue is expected to decrease by -10.41% on average over the next years. This is quite bad
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

ACLS is valuated correctly with a Price/Earnings ratio of 13.32.
Based on the Price/Earnings ratio, ACLS is valued cheaply inside the industry as 92.73% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.41. ACLS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 20.21, ACLS is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACLS indicates a somewhat cheap valuation: ACLS is cheaper than 70.91% of the companies listed in the same industry.
ACLS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 13.32
Fwd PE 20.21
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaper than 94.55% of the companies in the same industry.
85.45% of the companies in the same industry are more expensive than ACLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.45
EV/EBITDA 7.27
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
ACLS's earnings are expected to grow with 24.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y-22.39%
EPS Next 3Y24.02%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (7/11/2025, 8:00:00 PM)

After market: 74.86 0 (0%)

74.86

-0.79 (-1.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners104.06%
Inst Owner Change0%
Ins Owners0.95%
Ins Owner Change8.65%
Market Cap2.41B
Analysts72.86
Price Target88.86 (18.7%)
Short Float %16.77%
Short Ratio8.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.39%
Min EPS beat(2)20.83%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)49.55%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)32.98%
EPS beat(12)12
Avg EPS beat(12)27.59%
EPS beat(16)16
Avg EPS beat(16)26.09%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)1.02%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.12%
Revenue beat(8)7
Avg Revenue beat(8)1.66%
Revenue beat(12)11
Avg Revenue beat(12)1.99%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)6.09%
PT rev (3m)-5.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)47.47%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)41.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.78%
Valuation
Industry RankSector Rank
PE 13.32
Fwd PE 20.21
P/S 2.51
P/FCF 19.45
P/OCF 17.3
P/B 2.34
P/tB 2.34
EV/EBITDA 7.27
EPS(TTM)5.62
EY7.51%
EPS(NY)3.7
Fwd EY4.95%
FCF(TTM)3.85
FCFY5.14%
OCF(TTM)4.33
OCFY5.78%
SpS29.82
BVpS32
TBVpS32
PEG (NY)N/A
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROCE 16.13%
ROIC 14.18%
ROICexc 29.22%
ROICexgc 29.22%
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
FCFM 12.91%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ROICexc(3y)45.43%
ROICexc(5y)37.56%
ROICexgc(3y)45.43%
ROICexgc(5y)37.56%
ROCE(3y)24.31%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.57%
ROICexcg growth 5Y39.04%
ROICexc growth 3Y-3.57%
ROICexc growth 5Y39.04%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.21
Cap/Depr 92.8%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 69.32%
Profit Quality 69.08%
Current Ratio 5.57
Quick Ratio 4.09
Altman-Z 7.1
F-Score6
WACC11.68%
ROIC/WACC1.21
Cap/Depr(3y)109.59%
Cap/Depr(5y)96.82%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.12%
Profit Quality(5y)99.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%
Revenue Next Year-25.43%
Revenue Next 2Y-10.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.22%
EBIT growth 3Y18.35%
EBIT growth 5Y54.2%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.94%
FCF growth 3Y-3.04%
FCF growth 5YN/A
OCF growth 1Y-38.06%
OCF growth 3Y-2.08%
OCF growth 5YN/A